NDC product
good sense omeprazole delayed release
NDC 0113-1803 · L. Perrigo Company
Key facts
| Product NDC | 0113-1803 |
|---|---|
| Proprietary name | good sense omeprazole delayed release |
| Nonproprietary name | omeprazole |
| Substances | OMEPRAZOLE |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Labeler | L. Perrigo Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA022032 |
| Pharmacologic classes | Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| Marketing start | Dec 21, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: